DNA Test Lets 2 in 3 Breast Cancer Patients Skip Chemo

A groundbreaking gene test could spare millions of breast cancer patients from chemotherapy's harsh side effects while maintaining the same survival rates.

The international trial found that 67% of patients could safely skip chemo and use hormone therapy instead.